Skip to main content
Log in

Digoxin-like immunoreactive substance in serum of preterm and full-term neonates

  • Original Investigations
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

A significant serum level of digoxin-like immunoreactive substance (DLIS) (≥0.5 ng/ml) has been found in healthy full-term neonates, in prematurely born neonates as well as in full-term but small for gestational age neonates. Neither the babies nor their mothers had received digoxin therapy. On the first day of life, the incidence of serum levels of DLIS≥0.5 ng/ml in the three groups of neonates were respectively 64% (32/50), 42% (8/19) and 77% (10/13). Longitudinal measurements in preterm and small for gestational age neonates indicate a progressive disappearance of DLIS from their serum, none of them having a significant serum level at 21 days of age. As long as the chemical structure, origin and physiological properties of DLIS remain unknown, clinicians must be cautious in interpreting the serum levels of digoxin used for therapeutical purpose in neonates.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

DLIS:

digoxin-like immunoreactive substance

SGA:

small for gestational age

RIA:

radioimmunoassay

References

  1. Beyers AD, Odendaal HJ, Spruyt LL, Parkin DP (1984) The possible role of endogenous digitalis-like substance in the causation of pre-eclampsia. S Afr Med J 65:883–885

    CAS  PubMed  Google Scholar 

  2. Beyers AD, Spruyt LL, Seifart HI, Kriegler A, Parkin DP, Van Jaarsveld PP (1984) Endogenous immunoreactive digitalis-like substance in neonatal serum and placental extracts. S Afr Med J 65:878–882

    CAS  PubMed  Google Scholar 

  3. Ebara H, Suzuki S, Nagashima K, Koizumi T, Nishida A, Kambe Y, Kuroume T (1986) Digoxin — and digitoxin-like immunoreactive substances in amniotic fluid, cord blood, and serum of neonates. Pediatr Res 20:28–31

    CAS  PubMed  Google Scholar 

  4. Graves SW, Brown B, Valdes R (1983) An endogenous digoxin-like substance in patients with renal impairment. Ann Intern Med 99:604–608

    CAS  PubMed  Google Scholar 

  5. Graves SM, Valdes R, Brown BA Jr, Knight AB, Craig HR (1984) Endogenous digoxin immunoreactive substance in human pregnancies. J Clin Endocrinol Metab 58:748–751

    CAS  PubMed  Google Scholar 

  6. Kleigmuller D, Weiler E, Kramer HJ (1982) Digoxin-like natriuretic activity in the urine of salt-loaded healthy subjects. Klin Wochenschr 60:1249–1251

    Google Scholar 

  7. Lubchenco LO, Hansman C, Boyd E (1966) Intrauterine growth in length and headcircumference as estimated from live births at gestational ages from 26 to 42 weeks. Pediatrics 37:403–408

    CAS  PubMed  Google Scholar 

  8. Pudek MR, Seccombe DW, Whitfield MF (1983) Digoxin like immunoreactivity in premature and full-term infants not receiving digoxin therapy. N Engl J Med 308:904–905

    CAS  PubMed  Google Scholar 

  9. Pudek MR, Seccombe DW, Jacobson BE, Whitfield MF (1983) Seven different digoxin immunoassay kits compared with respect to intereference by a digoxin-like immunoreactive substance in serum from premature and full-term infants. Clin Chem 29 (11): 1972–1974

    CAS  PubMed  Google Scholar 

  10. Valdes R (1985) Endogenous digoxine-like immunoreactive factors: impact on digoxin measurement and potential physiological implications. Clin Chem 31 (9):1525–1532

    CAS  PubMed  Google Scholar 

  11. Valdes R, Graves SW, Brown BA, Landt M (1983) Endogenous substances in newborn infants causing false positive digoxin measurements. J Pediatr 102:947–950

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bertrand, J.M., Langhendries, J.P., Gras, A. et al. Digoxin-like immunoreactive substance in serum of preterm and full-term neonates. Eur J Pediatr 146, 145–146 (1987). https://doi.org/10.1007/BF02343220

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02343220

Key words

Navigation